| Authors: |
Francis PA; Peter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Breast Cancer Trials Australia & New Zealand, Newcastle, Australia; International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland. Electronic address: prue.francis@petermac.org., Pagani O; Geneva University Hospitals, Geneva, Switzerland; University Hospitals, Lugano University, Lugano, Switzerland; Swiss Cancer Institute (Formerly SAKK), Bern, Switzerland., Fleming GF; The University of Chicago Medical Center, Chicago, USA., Walley BA; University of Calgary and Canadian Cancer Trials Group, Calgary, AB, Canada., Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy., Rubovszky G; Department of Thoracic and Abdominal Tumors and Clinical Pharmacology, National Institute of Oncology, Budapest, Hungary., Tondini C; Carlo Tondini, MD Osp. Papa Giovanni XXIII, Bergamo, Italy., Ciruelos EM; Instituto de Investigacion Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain; SOLTI Breast Cancer Research Group, Barcelona, Spain., Gomez HL; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Bonnefoi HR; Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U1312, Bordeaux, France; European Organisation for Research and Treatment of Cancer (EORTC), Paris, France., Burstein HJ; Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, Boston, USA; Harvard Medical School, Boston, USA; Alliance for Clinical Trials in Oncology, Chicago, USA., Chini C; Department of Medical Oncology, Ospedale di Circolo e Fondazione, Lombardy, Italy., Puglisi F; Department of Medicine (DMED), University of Udine, Udine, Italy; Department of Medical Oncology, IRCCS, Centro di Riferimento Oncologico CRO di Aviano, Aviano, Italy., Spazzapan S; Department of Medical Oncology, IRCCS, Centro di Riferimento Oncologico CRO di Aviano, Aviano, Italy., Bernardo A; Medical Oncology Unit, ICS Maugeri-IRCCS, Pavia, Italy., Climent MA; SOLTI Breast Cancer Research Group, Barcelona, Spain; Instituto Valenciano de Oncologia, Valencia, Spain., Bellet M; SOLTI Breast Cancer Research Group, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Vall d'Hebron University Hospital, Barcelona, Spain., Ruhstaller T; Swiss Cancer Institute (Formerly SAKK), Bern, Switzerland; University of Basel, Basel, Switzerland., Bermejo B; SOLTI Breast Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA, Medicine Department Universidad de Valencia, Valencia, Spain., Chia SKL; Division of Medical Oncology, The University of British Columbia, Vancouver, BC, Canada; British Columbia Cancer Agency, Vancouver, BC, Canada; Canadian Cancer Trials Group, Kingston, ON, Canada., Martino S; The Angeles Clinic and Research Institute and SWOG, Santa Monica, USA., Geyer CE; University of Pittsburgh School of Medicine UPMC Hillman Cancer Center, Pittsburgh, USA; NRG Oncology, Philadelphia, USA., Goetz MP; Alliance for Clinical Trials in Oncology, Chicago, USA; Mayo Clinic, Rochester, USA., Ingle JN; Alliance for Clinical Trials in Oncology, Chicago, USA; Mayo Clinic, Rochester, USA., Stearns V; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medical School, New York, USA., Davidson NE; Fred Hutchinson Cancer Center, University of Washington, Seattle, USA; ECOG-ACRIN, Philadelphia, USA., Le Du F; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France., Müller B; Chilean Cooperative Group for Oncological Research (GOCCHI), Santiago, Chile., Coleman RE; Weston Park Hospital, Sheffield, UK; NCRI Breast Cancer Clinical Studies Group (NCRI-BCSG), London, UK; CR-CTSU, London, UK., Loibl S; Goethe University of Frankfurt, Frankfurt, Germany; German Breast Group, Neu-Isenburg, Germany., Winer EP; Yale Cancer Center, Yale School of Medicine, New Haven, USA., Ruepp B; ETOP IBCSG Partners Foundation Coordinating Center, Bern, Switzerland., Loi S; International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Melbourne, Australia; Division of Cancer Research, Peter MacCallum Cancer Center, Melbourne, Australia., Láng I; Clinexpert-research, Budapest, Hungary., Coates AS; International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland; University of Sydney, Sydney, Australia., Gelber RD; Harvard Medical School, Boston, USA; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Boston, USA; Department of Data Science, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, USA; Harvard TH Chan School of Public Health, Boston, USA; Frontier Science Foundation, Boston, USA., Goldhirsch A; Harvard Medical School, Boston, USA; IEO, European Institute of Oncology, IRCCS, Milan, Italy., Regan MM; Harvard Medical School, Boston, USA; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Boston, USA; Department of Data Science, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, USA. |
